chr6-158148854-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032861.4(SERAC1):​c.355+11A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.473 in 1,575,790 control chromosomes in the GnomAD database, including 180,558 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.43 ( 14960 hom., cov: 33)
Exomes 𝑓: 0.48 ( 165598 hom. )

Consequence

SERAC1
NM_032861.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.157

Publications

11 publications found
Variant links:
Genes affected
SERAC1 (HGNC:21061): (serine active site containing 1) The protein encoded by this gene is a phosphatidylglycerol remodeling protein found at the interface of mitochondria and endoplasmic reticula, where it mediates phospholipid exchange. The encoded protein plays a major role in mitochondrial function and intracellular cholesterol trafficking. Defects in this gene are a cause of 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome (MEGDEL). Two transcript variants, one protein-coding and the other non-protein coding, have been found for this gene. [provided by RefSeq, Aug 2012]
SERAC1 Gene-Disease associations (from GenCC):
  • 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • Leigh syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 6-158148854-T-C is Benign according to our data. Variant chr6-158148854-T-C is described in ClinVar as Benign. ClinVar VariationId is 139094.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.586 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SERAC1NM_032861.4 linkc.355+11A>G intron_variant Intron 5 of 16 ENST00000647468.2 NP_116250.3 Q96JX3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SERAC1ENST00000647468.2 linkc.355+11A>G intron_variant Intron 5 of 16 NM_032861.4 ENSP00000496731.1 Q96JX3-1

Frequencies

GnomAD3 genomes
AF:
0.429
AC:
65294
AN:
152044
Hom.:
14933
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.266
Gnomad AMI
AF:
0.309
Gnomad AMR
AF:
0.595
Gnomad ASJ
AF:
0.518
Gnomad EAS
AF:
0.432
Gnomad SAS
AF:
0.432
Gnomad FIN
AF:
0.453
Gnomad MID
AF:
0.554
Gnomad NFE
AF:
0.483
Gnomad OTH
AF:
0.446
GnomAD2 exomes
AF:
0.481
AC:
117002
AN:
243458
AF XY:
0.479
show subpopulations
Gnomad AFR exome
AF:
0.262
Gnomad AMR exome
AF:
0.667
Gnomad ASJ exome
AF:
0.527
Gnomad EAS exome
AF:
0.421
Gnomad FIN exome
AF:
0.456
Gnomad NFE exome
AF:
0.477
Gnomad OTH exome
AF:
0.499
GnomAD4 exome
AF:
0.478
AC:
679924
AN:
1423628
Hom.:
165598
Cov.:
24
AF XY:
0.478
AC XY:
338929
AN XY:
709540
show subpopulations
African (AFR)
AF:
0.258
AC:
8401
AN:
32514
American (AMR)
AF:
0.661
AC:
28450
AN:
43044
Ashkenazi Jewish (ASJ)
AF:
0.528
AC:
13589
AN:
25756
East Asian (EAS)
AF:
0.491
AC:
19261
AN:
39260
South Asian (SAS)
AF:
0.449
AC:
37187
AN:
82864
European-Finnish (FIN)
AF:
0.455
AC:
24249
AN:
53250
Middle Eastern (MID)
AF:
0.538
AC:
3058
AN:
5688
European-Non Finnish (NFE)
AF:
0.479
AC:
518490
AN:
1082176
Other (OTH)
AF:
0.461
AC:
27239
AN:
59076
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
15244
30488
45733
60977
76221
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15134
30268
45402
60536
75670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.430
AC:
65357
AN:
152162
Hom.:
14960
Cov.:
33
AF XY:
0.432
AC XY:
32145
AN XY:
74388
show subpopulations
African (AFR)
AF:
0.267
AC:
11066
AN:
41516
American (AMR)
AF:
0.596
AC:
9114
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.518
AC:
1799
AN:
3470
East Asian (EAS)
AF:
0.432
AC:
2242
AN:
5186
South Asian (SAS)
AF:
0.434
AC:
2095
AN:
4826
European-Finnish (FIN)
AF:
0.453
AC:
4794
AN:
10576
Middle Eastern (MID)
AF:
0.548
AC:
160
AN:
292
European-Non Finnish (NFE)
AF:
0.483
AC:
32857
AN:
67984
Other (OTH)
AF:
0.449
AC:
948
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1877
3754
5631
7508
9385
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
602
1204
1806
2408
3010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.472
Hom.:
9828
Bravo
AF:
0.434
Asia WGS
AF:
0.417
AC:
1449
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 05, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome Benign:2
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
1.7
DANN
Benign
0.42
PhyloP100
0.16
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9356399; hg19: chr6-158569886; COSMIC: COSV65595966; API